cromolyn sodium has been researched along with prostaglandin d2 in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (37.50) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benyon, RC; Church, MK; Hillier, K; Lowman, MA; Okayama, Y; Rees, PH | 1 |
Church, MK; Okayama, Y | 1 |
Bulbena, O; Catafau, JR; Gelpi, E; Picado, C; Ramis, I; Serra, J | 1 |
Eady, RP; Harper, ST; Jackson, CG; Mann, J; Wells, E | 1 |
Church, MK; Hiroi, J | 1 |
Ishii, A; Kawabe, H; Kosaka, Y | 1 |
Beasley, R; Church, MM; Featherstone, RL; Holgate, ST; Lai, C | 1 |
Broide, DH; Metcalfe, DD; Wasserman, SI | 1 |
Norman, PS | 1 |
Bousquet, J; Campbell, AM; Demoly, P; Michel, FB | 1 |
Anderson, SD; Brannan, JD; Chew, N; Gulliksson, M; Kumlin, M; Seale, JP | 1 |
Austen, KF | 1 |
Antoniou, C; Asadi, S; Butcher, A; Fu, X; Katsarou-Katsari, A; Sismanopoulos, N; Theoharides, TC; Weng, Z; Zhang, B | 1 |
Calder, V; Flower, RJ; Sinniah, A; Solito, E; Yazid, S | 1 |
Chen, M; Christiansen, S; Doherty, TA; Kim, A; Zuraw, B | 1 |
Butterfield, J; Castells, M | 1 |
1 review(s) available for cromolyn sodium and prostaglandin d2
Article | Year |
---|---|
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromolyn Sodium; Disease Management; Glucocorticoids; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Hydroxyurea; Interleukin-6; Leukotriene Antagonists; Leukotriene E4; Mastocytosis; Omalizumab; Prostaglandin D2; Tryptases | 2019 |
1 trial(s) available for cromolyn sodium and prostaglandin d2
Article | Year |
---|---|
Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Asthma; Bronchoconstriction; Cromolyn Sodium; Cross-Over Studies; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Humans; Male; Mannitol; Mast Cells; Prostaglandin D2 | 2006 |
14 other study(ies) available for cromolyn sodium and prostaglandin d2
Article | Year |
---|---|
Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine.
Topics: Adenoids; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cromolyn Sodium; Cross Reactions; Histamine Release; Humans; Infant; Intestines; Kinetics; Lung; Mast Cells; Middle Aged; Nedocromil; Palatine Tonsil; Prostaglandin D2; Quinolones; Skin; Tachyphylaxis | 1992 |
Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells.
Topics: Albuterol; Bronchodilator Agents; Child; Child, Preschool; Cromolyn Sodium; Dose-Response Relationship, Drug; Ethanolamines; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Infant; Infant, Newborn; Ketotifen; Lung; Male; Mast Cells; Palatine Tonsil; Procaterol; Prostaglandin D2; Skin; Time Factors | 1992 |
In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions.
Topics: Adolescent; Adult; Analysis of Variance; Arachidonic Acid; Cromolyn Sodium; Dinoprost; Dinoprostone; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxygenase; Male; Middle Aged; Nasal Mucosa; Nasal Provocation Tests; Prostaglandin D2; Rhinitis, Allergic, Perennial | 1991 |
Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Topics: Animals; Antibodies, Anti-Idiotypic; Ascariasis; Bronchi; Cromolyn Sodium; Histamine Release; Immunoglobulin E; Macaca; Mast Cells; Nedocromil; Peritoneal Cavity; Prostaglandin D2; Prostaglandins D; Pulmonary Alveoli; Quinolines; Rats; SRS-A | 1986 |
Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Topics: Albuterol; Cromolyn Sodium; Cross Reactions; Histamine Antagonists; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Lung; Mast Cells; Prostaglandin D2; Prostaglandins D | 1987 |
Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Cromolyn Sodium; Guinea Pigs; Ketotifen; Lung; Mast Cells; ortho-Aminobenzoates; Piperazines; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins D; Rats; SRS-A | 1987 |
The mediator and cellular basis of the allergic response.
Topics: Animals; Asthma; Benzhydryl Compounds; Cromolyn Sodium; Eosinophils; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Mast Cells; Prostaglandin D2; Terfenadine | 1988 |
Functional and biochemical characterization of rat bone marrow derived mast cells.
Topics: Animals; beta-N-Acetylhexosaminidases; Bone Marrow; Cell Division; Cells, Cultured; Cromolyn Sodium; Cytoplasmic Granules; Male; Mast Cells; Mucous Membrane; Prostaglandin D2; Proteoglycans; Rats; Rats, Inbred Strains; SRS-A | 1988 |
The John Sheldon memorial lecture. Review of nasal therapy: update.
Topics: Absorption; Cromolyn Sodium; Dexamethasone; Histamine H1 Antagonists; Histamine Release; Humans; Immunotherapy; Nasal Provocation Tests; Peptide Hydrolases; Prostaglandin D2; Prostaglandins D; Rhinitis; Rhinitis, Allergic, Perennial; Skin Tests; Steroids; Sympathomimetics; Time Factors | 1983 |
Conjunctival provocation tests with codeine phosphate. Effect of disodium cromoglycate.
Topics: Adult; Codeine; Conjunctiva; Conjunctivitis; Cromolyn Sodium; Histamine Release; Humans; Mast Cells; Prostaglandin D2 | 1993 |
Doing what I like.
Topics: Allergy and Immunology; Androstanols; Angioedemas, Hereditary; Bronchoconstriction; CD55 Antigens; Complement Activation; Complement Pathway, Alternative; Cromolyn Sodium; Hemoglobinuria, Paroxysmal; History, 20th Century; History, 21st Century; Mast Cells; Prostaglandin D2; Receptors, Leukotriene; SRS-A; Stem Cells; United States | 2008 |
Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans.
Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antigen-Antibody Complex; Calcium; Cells, Cultured; Cromolyn Sodium; Dermatitis, Contact; Histamine; Humans; Hypersensitivity; Immunoglobulin E; Interleukin-6; Interleukin-8; Leukotrienes; Mast Cells; NF-kappa B; Prostaglandin D2; Quercetin | 2012 |
Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1.
Topics: Animals; Annexin A1; Anti-Allergic Agents; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Cells, Cultured; Cromolyn Sodium; Dexamethasone; Eicosanoids; Histamine Release; Humans; Immunoglobulin E; Mast Cells; Mice; Mice, Knockout; Nedocromil; Phosphorylation; Prostaglandin D2; Recombinant Proteins | 2013 |
Mast cell disorders: Protean manifestations and treatment responses.
Topics: Abdominal Pain; Adult; Anaphylaxis; Angioedema; Anti-Asthmatic Agents; Biomarkers; Cromolyn Sodium; Diarrhea; Dinoprost; Female; Histamine Antagonists; Humans; Leukotriene E4; Male; Mast Cells; Mastocytosis; Middle Aged; Omalizumab; Prostaglandin D2; Treatment Outcome; Tryptases; Urticaria | 2018 |